Prevalence of fragility fractures in women with SLE, their connexion with the course of the disease and the nature of pharmacotherapy

Shevchuk, S.; Denyschych, L.; Shevchuk, E.

Home
→
НДІ реабілітації інвалідів
→
Наукові публікації НДІ реабілітації інвалідів
→
View Item

dc.contributor.author	Shevchuk, S.	en
dc.contributor.author	Denyschych, L.	en
dc.contributor.author	Shevchuk, E.	en
dc.date.accessioned	2020-03-13T07:56:19Z
dc.date.available	2020-03-13T07:56:19Z
dc.date.issued	2018
dc.identifier.citation	Shevchuk S. Prevalence of fragility fractures in women with SLE, their connexion with the course of the disease and the nature of pharmacotherapy / S. Shevchuk, L. Denyschych, E. Shevchuk // Conference Paper in: Annals of the Rheumatic Diseases / EULAR (Amsterdam). – 2018. – Vol. 77,suppl. 2. – Р. 1994.	en
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/4490
dc.description.abstract	The aim of the study was to determine the frequency of osteoporosis and fragility fractures in the Ukrainian systemic lupus erythematosus (SLE) patients and to establish their connection with the course of the disease. The main study group involved 91 women with a diagnosis of SLE according to the American College of Rheumatology criteria. In patients with SLE the prevalence of low bone mineral density (BMD) and fragility fractures is high. Progressive loss of the BMD and the occurrence of osteoporotic fractures are closely associated with the severity of organ damage and glucocorticoids use.	en
dc.language.iso	en	en
dc.subject	systemic lupus erythematosus (SLE)	en
dc.subject	osteoporosis	en
dc.subject	bone mineral density	en
dc.subject	course of the disease	en
dc.subject	pharmacotherapy	en
dc.subject	glucocorticoids	en
dc.title	Prevalence of fragility fractures in women with SLE, their connexion with the course of the disease and the nature of pharmacotherapy	en
dc.type	Thesis	en